Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?
Department of Rheumatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Royal Lancaster Infirmary, Ashton Road, LA1 4RP, Lancaster, UK. marco.massarotti@mbht.nhs.uk.|Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (Milan), Italy. marco.massarotti@mbht.nhs.uk.
M
M
Massarotti
Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (Milan), Italy.
G
G
Fabbriciani
Interventional Pain Unit, Galeazzi Institute, Milan, Italy.
M
M
Barbieri
Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (Milan), Italy.
M
M
De Santis
Department of Rheumatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Royal Lancaster Infirmary, Ashton Road, LA1 4RP, Lancaster, UK.
M
M
Bukhari
D001843:Bone Cements; D050815:Fractures, Compression; D006801:Humans; D058498:Kyphoplasty; D016103:Spinal Fractures; D054854:Vertebroplasty
D001843:Bone Cements